WHO ICTRP trial
A randomised controlled trial of bisphosphonate therapy in osteonecrosis of the…
ACTRN12609000104257 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12609000104257 |
|---|---|
| Public title | A randomised controlled trial of bisphosphonate therapy in osteonecrosis of the hip. |
| Scientific title | A randomised controlled trial to study the effectiveness of potent bisphosphonate (Zoledronic Acid) therapy in patients with early osteonecrosis of the hip. |
| Primary sponsor | University of Sydney/ Northern Clinical School |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | osteonecrosis of the hip;collapse femoral head; osteonecrosis of the hip collapse femoral head;Musculoskeletal - Other muscular and skeletal disorders |
| Interventions | Participants will be randomised to one of two groups, the intervention (zoledronic acid infusion) and control group (placebo infusion). Participants will have a 66% chance of being in the intervention group and a 33% chance of being in the… |
| Registration date | Feb 13, 2009 |
| Target size | 120 |
| Secondary IDs | BONES Study |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: